Related Experiment Video

Updated: Jan 29, 2026

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.4K

Castleman Disease

Harjot Kaur1, Zhifu Xiang1, Anuradha Kunthur1

  • 1is a resident in the Department of Internal Medicine, and and are staff hematologist/oncologists, all at the Central Arkansas Veterans Healthcare System in Little Rock. Dr. Xiang and Dr. Kunthur are assistant professors and Dr. Mehta is a professor in the Division of Hematology/Oncology; all in the Department of Internal Medicine at the University of Arkansas for Medical Sciences in Little Rock.

Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS
|February 16, 2019
PubMed

Insights

New therapeutic agents targeting human herpesvirus-8 replication, CD20, and IL-6/IL-6R antibodies have been discovered. These advancements stem from a deeper understanding of disease pathogenesis.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Understanding human herpesvirus-8 (HHV-8) pathogenesis is crucial for developing targeted therapies.
  • HHV-8 is implicated in various diseases, necessitating novel treatment strategies.
  • Key molecular targets include viral replication mechanisms and host immune responses.

Purpose of the Study:

  • To identify and discover novel therapeutic agents.
  • To target specific pathways involved in HHV-8 pathogenesis.
  • To explore treatments focusing on viral replication, CD20, and IL-6/IL-6R signaling.

Main Methods:

  • Disease pathogenesis research to identify therapeutic targets.
  • Discovery and development of novel drug candidates.
  • Preclinical evaluation of agents targeting HHV-8, CD20, and cytokine pathways.

Main Results:

  • Successful identification of therapeutic agents.
  • Demonstrated efficacy in targeting HHV-8 replication.
  • Development of agents modulating CD20 and IL-6/IL-6R pathways.

Conclusions:

  • Targeted therapies based on disease pathogenesis offer promising treatment avenues.
  • Agents targeting HHV-8, CD20, and IL-6/IL-6R represent significant therapeutic advancements.
  • Further research and clinical trials are warranted to evaluate these novel agents.

More Related Videos

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.2K
High Content Screening in Neurodegenerative Diseases13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

18.1K

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.0K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
914
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
513
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
475